WuXi AppTec has repurchased a total of 23.9346 million A-shares

robot
Abstract generation in progress

On September 29th, 金十数据 learned that in Hong Kong Stock Exchange's announcement, CStone Pharmaceuticals has completed its third share buyback in 2024, with a total of 23.9346 million A-shares repurchased through centralized Bidding trading, accounting for 0.82% of the total issuance as of the date of this announcement. The highest price for the third share buyback in 2024 was RMB 44.43 per A-share, and the lowest price was RMB 37.37 per A-share. The average price of the third share buyback in 2024 was RMB 41.78 per A-share, with a total funding of RMB 1 billion.

View Original
  • Reward
  • 1
  • Share
Comment
No comments